JW Pharmaceutical Corporation (KRX:001060)
South Korea flag South Korea · Delayed Price · Currency is KRW
32,100
-400 (-1.23%)
Apr 29, 2026, 3:30 PM KST

JW Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
39,23310,43015,90933,89833,366
Upgrade
Short-Term Investments
10,10822,12148,28853,78132,300
Upgrade
Trading Asset Securities
12,000-30,00062,000-
Upgrade
Cash & Short-Term Investments
61,34132,55194,196149,67865,666
Upgrade
Cash Growth
88.45%-65.44%-37.07%127.94%18.76%
Upgrade
Accounts Receivable
114,573135,503159,378147,523151,780
Upgrade
Other Receivables
3,5813,5715,6445,9625,499
Upgrade
Receivables
118,154155,763173,521156,362187,379
Upgrade
Inventory
109,897111,733106,091111,668102,528
Upgrade
Prepaid Expenses
2,2161,8831,8481,7745,152
Upgrade
Other Current Assets
4,9044,4842,4345,9755,727
Upgrade
Total Current Assets
296,512306,413378,091425,457366,452
Upgrade
Property, Plant & Equipment
165,279172,291155,724123,048118,392
Upgrade
Long-Term Investments
33,24063,80136,99533,95798,884
Upgrade
Goodwill
--1,404--
Upgrade
Other Intangible Assets
12,87710,87812,24811,75012,773
Upgrade
Long-Term Deferred Tax Assets
20,36313,56920,62321,81120,802
Upgrade
Long-Term Deferred Charges
51,58129,95816,7044,5168,700
Upgrade
Other Long-Term Assets
9,1447,6887,746269.554,050
Upgrade
Total Assets
605,273604,599645,039627,973633,053
Upgrade
Accounts Payable
55,86459,61373,84782,90851,643
Upgrade
Accrued Expenses
32,84222,20414,49512,47210,343
Upgrade
Short-Term Debt
20,00031,40072,96846,00081,823
Upgrade
Current Portion of Long-Term Debt
12,10210,00040,166160,44039,977
Upgrade
Current Portion of Leases
4,0794,3524,2701,2531,274
Upgrade
Current Income Taxes Payable
12,9647,79411,11410,15324,877
Upgrade
Current Unearned Revenue
174.55159.58159.58153.65551.41
Upgrade
Other Current Liabilities
71,13373,09269,90766,75272,188
Upgrade
Total Current Liabilities
209,159208,615286,927380,131282,678
Upgrade
Long-Term Debt
-25,10230,000-120,744
Upgrade
Long-Term Leases
18,45420,87222,8761,8491,326
Upgrade
Long-Term Unearned Revenue
997.41,1571,317--
Upgrade
Pension & Post-Retirement Benefits
1,0805,89210,3217,31422,402
Upgrade
Long-Term Deferred Tax Liabilities
1,1061,1661,2761,399-
Upgrade
Other Long-Term Liabilities
5,10812,30926,88211,52017,364
Upgrade
Total Liabilities
235,904275,112379,598402,214444,514
Upgrade
Common Stock
62,25362,25361,10059,41857,202
Upgrade
Additional Paid-In Capital
68,32168,32169,47571,06363,334
Upgrade
Retained Earnings
214,569164,123113,02989,13058,595
Upgrade
Treasury Stock
-21,616-12,076-11,325-11,065-10,783
Upgrade
Comprehensive Income & Other
45,84246,86533,16231,80832,847
Upgrade
Total Common Equity
369,370329,487265,440240,354201,195
Upgrade
Minority Interest
000-14,595-12,655
Upgrade
Shareholders' Equity
369,370329,487265,440225,759188,540
Upgrade
Total Liabilities & Equity
605,273604,599645,039627,973633,053
Upgrade
Total Debt
54,63591,726170,280209,542245,145
Upgrade
Net Cash (Debt)
6,706-59,175-76,084-59,864-179,479
Upgrade
Net Cash Per Share
276.26-2405.58-3196.37-2577.51-7733.47
Upgrade
Filing Date Shares Outstanding
27.9922.9722.5422.3422.35
Upgrade
Total Common Shares Outstanding
27.9923.3123.3323.3423.21
Upgrade
Working Capital
87,35397,79891,16445,32683,774
Upgrade
Book Value Per Share
13194.1614136.8211375.9210299.988669.19
Upgrade
Tangible Book Value
356,493318,608251,788228,604188,422
Upgrade
Tangible Book Value Per Share
12734.2013670.0810790.839796.448118.81
Upgrade
Land
44,53644,53626,55522,17822,178
Upgrade
Buildings
120,753120,046112,052110,929110,161
Upgrade
Machinery
163,999173,804169,111158,179151,192
Upgrade
Construction In Progress
3,1283,5886,0648,128849.45
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.